Clinical Trial Update: Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on veliparib with or without radiation therapy, carboplatin, and paclitaxel in patients with unresectable Stage III non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Veliparib (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Adenocarcinoma, Lung Adenocarcinoma, Mixed Subtype | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-07-12